Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorFOURGEAUD, Mélanie
dc.contributor.authorLEBRETON, Louis
dc.contributor.authorBELABBAS, Khaldia
dc.contributor.authorDI FILIPPO, Mathilde
dc.contributor.authorRIGALLEAU, Vincent
IDREF: 069788146
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCOUFFINHAL, Thierry
dc.contributor.authorPUCHEU, Yann
dc.contributor.authorBARAT, Pascal
dc.contributor.authorGED, Cécile
dc.contributor.authorBÉRARD, Annie M
dc.date.accessioned2022-09-16T10:04:44Z
dc.date.available2022-09-16T10:04:44Z
dc.date.created2022
dc.date.issued2022-03-17
dc.identifier.issn1933-2874en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/147960
dc.description.abstractEnFamilial hypercholesterolemia (FH) is the most common genetic disorder associated with a high risk for premature atherosclerotic cardiovascular disease attributable to increased levels of LDL-cholesterol (LDL-C) from birth. FH is both underdiagnosed and undertreated. We describe the clinical, biological, and genetic characteristics of 147 patients in France with clinical FH (including a group of 26 subjects aged < 20 years); we explore how best to detect patients with monogenic FH. We retrospectively reviewed all available data on patients undergoing genetic tests for FH from 2009 to 2019. FH diagnoses were based on the Dutch Lipid Clinics Network (DLCN) scores of adults, and elevated LDL-C levels in subjects < 20 years of age. We evaluated LDLR, APOB, and PCSK9 status. The mutations of adults (in 25.6% of all adults) were associated with DLCN scores indicating "possible FH," "probable FH, and "definitive FH" at rates of 4%, 16%, and 53%, respectively. The areas under the ROC curves of the DLCN score and the maximum LDL-C level did not differ (p = 0.32). We found that the pediatric group evidenced more monogenic etiologies (77%, increasing to 91% when an elevated LDL-C level was combined with a family history of hypercholesterolemia and/or premature coronary artery disease). Diagnosis of monogenic FH may be optimized by screening children in terms of their LDL-C levels, associated with reverse-cascade screening of relatives when the children serve as index cases.
dc.language.isoENen_US
dc.subjectArticle clinique
dc.subject.enAdult
dc.subject.enChild
dc.subject.enCholesterol
dc.subject.enLDL
dc.subject.enHumans
dc.subject.enHyperlipoproteinemia Type II
dc.subject.enProprotein Convertase 9
dc.subject.enRetrospective Studies
dc.subject.enYoung Adult
dc.title.enPhenotypic and genotypic characterization of familial hypercholesterolemia in French adult and pediatric populations.
dc.title.alternativeJ Clin Lipidolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jacl.2022.03.002en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed35379577en_US
bordeaux.journalJournal of clinical lipidologyen_US
bordeaux.page298-305en_US
bordeaux.volume16en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires (BMC) - UMR 1034en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Journal%20of%20clinical%20lipidology&amp;rft.date=2022-03-17&amp;rft.volume=16&amp;rft.issue=3&amp;rft.spage=298-305&amp;rft.epage=298-305&amp;rft.eissn=1933-2874&amp;rft.issn=1933-2874&amp;rft.au=FOURGEAUD,%20M%C3%A9lanie&amp;LEBRETON,%20Louis&amp;BELABBAS,%20Khaldia&amp;DI%20FILIPPO,%20Mathilde&amp;RIGALLEAU,%20Vincent&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée